The use of probiotics in IBD and IBS

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

While the role of microflora is well established in the development of inflammatory bowel disease (IBS); data is still emerging regarding IBS as the knowledge on brain-gut interaction grows. For both patient groups multiple efficacious treatments exist, but there are still unmet needs as long term disease control remains an issue. Given the importance of the microbiome on the development of the immune system and the interaction between the microbiome and the host organism, this "route" is being examined increasingly as a therapeutic possibility in both pathologies with variable Results: We here provide a short overview on the existing data, meta-analysis and single studies, on probiotic treatment in both diseases. Copyright © 1996-2014;.
Original languageEnglish
Title of host publicationMinerva Pediatrica
PublisherEdizioni Minerva Medica S.p.A.
Pages491-500
Number of pages10
ISBN (Print)0026-4946 (Print)\r0026-4946
Publication statusPublished - 1 Oct 2014

Publication series

NameMinerva Pediatrica
Volume66

Keywords

  • Colitis
  • Crohn disease
  • Inflammatory bowel diseases
  • Irritable bowel syndrome
  • Probiotics
  • Ulcerative

Fingerprint

Dive into the research topics of 'The use of probiotics in IBD and IBS'. Together they form a unique fingerprint.

Cite this